This attack does 70 damage for each Prize card your opponent has taken.
This Pokémon also does 50 damage to itself.
Release year for Paldean Fates is 2024. Series classification for this set is Scarlet & Violet.
The checklist contains 245 cards, placing it in a large expansion range. As of 2026, the set is 2 years old and still in a recent release window.
Within this set, Annihilape is card number 171 with a Shiny Rare designation.
Annihilape is a Paldean Fates card from the 2024 release window. The printed flavor text states: "It imbues its fists with the power of the rage that it kept hidden in its heart.
Opponents struck by these imbued fists will be shattered to their core." Its card type is Pokémon. The rarity label is Shiny Rare.
Printed HP is 140. Energy typing is Fighting.
As an evolution, Annihilape develops from Primeape. Attack line includes "Rage Fist" and "Dynamite Punch".
Current market pricing for Annihilape (Paldean Fates) sits near $2.91. Week-over-week change is limited (+1.4%), indicating short-term stability.
Relative to the last 30 days, value is near baseline at $2.86. Its 90-day trading band runs between $2.52 and $3.39, producing a 30% range and moderate-volatility behavior.
This version is categorized as Shiny Rare.
Collectors tracking Annihilape often benchmark it against other Annihilape cards. This comparison sample includes 4 alternatives across 4 sets.
Observed alternatives run from $0.08 to $0.17 (113% spread). The current card sits +2276% versus the sampled alternative average of $0.12.
Notable alternatives include Annihilape #100 (Surging Sparks) at $0.08, Annihilape #47 (Paldean Fates) at $0.11, Annihilape #92 (Destined Rivals) at $0.13, and Annihilape #109 (Scarlet & Violet) at $0.17.
Market structure summary: We observe a +1.4% shift this week, which points toward price consolidation rather than immediate volatility. With a 30% 90-day spread ($2.52-$3.39), this card currently tracks as moderate-volatility.
Relative to the 30-day baseline ($2.86), pricing is near equilibrium. Graded context points to a substantial premium curve, with PSA 10 at +1874% above raw pricing.
PSA 9 is currently around $21.11, while PSA 10 is $57.45.
